MetLife Investment Management, LLC - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 108 filers reported holding ENZO BIOCHEM INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q1 2018$120,000
-33.0%
21,9850.0%0.00%
-50.0%
Q4 2017$179,00021,9850.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q1 2018
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,886,771$10,219,00013.54%
HARBERT FUND ADVISORS, INC. 5,175,913$18,323,0006.51%
Evermore Global Advisors, LLC 1,730,607$6,126,0005.39%
VIEX Capital Advisors, LLC 1,510,401$5,347,0003.24%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$90,0000.05%
RBF Capital, LLC 250,359$886,0000.05%
CORRADO ADVISORS, LLC 19,366$69,0000.04%
Cutter & CO Brokerage, Inc. 27,827$99,0000.02%
Ergoteles LLC 177,048$627,0000.02%
FULLER & THALER ASSET MANAGEMENT, INC. 941,760$3,334,0000.02%
View complete list of ENZO BIOCHEM INC shareholders